Related Experiment Video
Updated: Jan 18, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With
Rie Tohge1, Kazuki Utsumi1, Katsuaki Miki2
1Neurology, Kansai Medical University Medical Center, Moriguchi, JPN.
Abstract:
We report a case of an 80-year-old man with small-cell lung cancer who developed paraneoplastic neurological syndrome (PNS) after four years of immune checkpoint inhibitor (ICI) therapy (atezolizumab). The patient presented with bilateral optic neuropathy, parkinsonism, and truncal ataxia. MRI revealed lesions in the basal ganglia and medial temporal lobes. Serological testing revealed a marked elevation of tumor markers, along with the presence of anti-CV2/CRMP5, anti-Hu, and anti-SOX1 antibodies. PNS onset may be primarily triggered by tumor recurrence, with long-term ICI exposure further amplifying the underlying immune response.
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Related Concept Videos
Tumor Immunotherapy
Treatment Resistant Cancers
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...